The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990–1999) at the Massachusetts General Hospital
Authors:
- 1 February 2004
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 92 (2) , 648-652
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Trimetrexate in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus: A Phase II Study of the Gynecologic Oncology GroupGynecologic Oncology, 2002
- Hepatic Metastases From LeiomyosarcomaAnnals of Surgery, 2000
- Phase II Trial of Paclitaxel in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group StudyGynecologic Oncology, 1999
- Phase II Trial of Etoposide in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group StudyGynecologic Oncology, 1996
- Ifosfamide and Doxorubicin in the Treatment of Advanced Leiomyosarcomas of the Uterus: A Gynecologic Oncology Group StudyGynecologic Oncology, 1996
- Uterine Leiomyosarcoma: Analysis of Treatment Failures and SurvivalGynecologic Oncology, 1996
- Problematic Uterine Smooth Muscle NeoplasmsAmerican Journal of Surgical Pathology, 1994
- Uterine Leiomyosarcoma and Endometrial Stromal Sarcoma: Lymph Node Metastases and Sites of RecurrenceGynecologic Oncology, 1993
- Prognostic factors in early‐stage uterine sarcoma: A gynecologic oncology group studyCancer, 1993
- Uterine sarcomasHuman Pathology, 1970